BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15207261)

  • 1. NDRG2: a novel Alzheimer's disease associated protein.
    Mitchelmore C; Büchmann-Møller S; Rask L; West MJ; Troncoso JC; Jensen NA
    Neurobiol Dis; 2004 Jun; 16(1):48-58. PubMed ID: 15207261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel cytosolic RING finger protein dactylidin is up-regulated in brains of patients with Alzheimer's disease.
    von Rotz RC; Kins S; Hipfel R; von der Kammer H; Nitsch RM
    Eur J Neurosci; 2005 Mar; 21(5):1289-98. PubMed ID: 15813938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.
    Lafay-Chebassier C; Paccalin M; Page G; Barc-Pain S; Perault-Pochat MC; Gil R; Pradier L; Hugon J
    J Neurochem; 2005 Jul; 94(1):215-25. PubMed ID: 15953364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic prostaglandin D synthase and DP1 receptor are selectively upregulated in microglia and astrocytes within senile plaques from human patients and in a mouse model of Alzheimer disease.
    Mohri I; Kadoyama K; Kanekiyo T; Sato Y; Kagitani-Shimono K; Saito Y; Suzuki K; Kudo T; Takeda M; Urade Y; Murayama S; Taniike M
    J Neuropathol Exp Neurol; 2007 Jun; 66(6):469-80. PubMed ID: 17549007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease.
    Page G; Rioux Bilan A; Ingrand S; Lafay-Chebassier C; Pain S; Perault Pochat MC; Bouras C; Bayer T; Hugon J
    Neuroscience; 2006; 139(4):1343-54. PubMed ID: 16581193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology.
    Berson A; Knobloch M; Hanan M; Diamant S; Sharoni M; Schuppli D; Geyer BC; Ravid R; Mor TS; Nitsch RM; Soreq H
    Brain; 2008 Jan; 131(Pt 1):109-19. PubMed ID: 18056160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuronal expression of vimentin in the Alzheimer's disease brain may be part of a generalized dendritic damage-response mechanism.
    Levin EC; Acharya NK; Sedeyn JC; Venkataraman V; D'Andrea MR; Wang HY; Nagele RG
    Brain Res; 2009 Nov; 1298():194-207. PubMed ID: 19728994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Abeta11-40/42 peptide deposition in Alzheimer's disease and young Down's syndrome brains: implication of N-terminally truncated Abeta species in the pathogenesis of Alzheimer's disease.
    Liu K; Solano I; Mann D; Lemere C; Mercken M; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2006 Aug; 112(2):163-74. PubMed ID: 16865398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal estrogen receptor-alpha splice variant TADDI in the human brain in aging and Alzheimer's disease.
    Ishunina TA; Swaab DF
    Neuroendocrinology; 2009; 89(2):187-99. PubMed ID: 18815440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
    Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer's disease.
    Feng Z; Qin C; Chang Y; Zhang JT
    Free Radic Biol Med; 2006 Jan; 40(1):101-9. PubMed ID: 16337883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.
    Frank S; Copanaki E; Burbach GJ; Müller UC; Deller T
    Neurosci Lett; 2009 Mar; 453(1):41-4. PubMed ID: 19429012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progranulin expression correlates with dense-core amyloid plaque burden in Alzheimer disease mouse models.
    Pereson S; Wils H; Kleinberger G; McGowan E; Vandewoestyne M; Van Broeck B; Joris G; Cuijt I; Deforce D; Hutton M; Van Broeckhoven C; Kumar-Singh S
    J Pathol; 2009 Oct; 219(2):173-81. PubMed ID: 19557827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered splicing in exon 8 of the DNA replication factor CIZ1 affects subnuclear distribution and is associated with Alzheimer's disease.
    Dahmcke CM; Büchmann-Møller S; Jensen NA; Mitchelmore C
    Mol Cell Neurosci; 2008 Aug; 38(4):589-94. PubMed ID: 18583151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
    Lee KW; Kim JB; Seo JS; Kim TK; Im JY; Baek IS; Kim KS; Lee JK; Han PL
    J Neurochem; 2009 Jan; 108(1):165-75. PubMed ID: 19012747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Alzheimer disease-related calcium-binding protein Calmyrin is present in human forebrain with an altered distribution in Alzheimer's as compared to normal ageing brains.
    Bernstein HG; Blazejczyk M; Rudka T; Gundelfinger ED; Dobrowolny H; Bogerts B; Kreutz MR; Kuznicki J; Wojda U
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):314-24. PubMed ID: 15885068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease.
    Wu ZL; Ciallella JR; Flood DG; O'Kane TM; Bozyczko-Coyne D; Savage MJ
    Neurobiol Aging; 2006 Mar; 27(3):377-86. PubMed ID: 15927307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease.
    Glatz DC; Rujescu D; Tang Y; Berendt FJ; Hartmann AM; Faltraco F; Rosenberg C; Hulette C; Jellinger K; Hampel H; Riederer P; Möller HJ; Andreadis A; Henkel K; Stamm S
    J Neurochem; 2006 Feb; 96(3):635-44. PubMed ID: 16371011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.